다형성아교모세포종 환자에서 cyclooxygenase-2 발현이 생존율에 미치는 영향 = Impact of cyclooxygenase-2 expression on the survival of glioblastoma

참고문헌 (Reference)

1 Souhami L, "Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol" 60 : 853-860, 2004

2 Stupp R, "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma" 352 : 987-996, 2005

3 Cho JH, "Radiation dose-escalation trial for glioblastomas with 3D-conformal radiotherapy" 22 : 237-246, 2004

4 Kowalczuk A, "Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas" 41 : 1028-1036, 1997

5 Chinery R, "Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells" 59 : 2739-2746, 1999

6 Wallner KE, "Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma" 1405-1409,

7 Deininger MH, "Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo" 98 : 240-244, 1999

8 Sheng H, "Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells" 58 : 362-366, 1998

9 Nam DH, "Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib" 11 : 263-268, 2004

10 Simpson JR, "Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme results of three consecutive Radiation Therapy Oncology Group" 239-244,

11 Buccoliero AM, "Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations" 25 : 59-66, 2006

12 Kirschenbaum A, "Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts" 85 : 3436-3441, 2000

13 Joki T, "Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398" 60 : 4926-4931, 2000

14 Yamagata K, "Expression of a mitogen-inducible cyclooxygenase in brain neurons regulation by synaptic activity and glucocorticoids" 371-386, neuron1993;11

15 Petersen C, "Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor" 6 : 2513-2520, 2000

16 Sawaoka H, "Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development" 27 : S47-S52, 1998

17 Yasojima K, "Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs" 830 : 226-236, 1999

18 Kardosh A, "Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines" 3 : 55-62, 2004

19 Karim A, "Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines" 25 : 675-679, 2005

20 Tomozawa S, "Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer" 83 : 324-328, 2000

21 Lin MT, "Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway" 276 : 48997-49002, 2001

22 Uefuji K, "Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer" 6 : 135-138, 2000

23 Shono T, "Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations" 61 : 4375-4381, 2001

24 Kakiuchi Y, "Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis" 62 : 1567-1572, 2002

25 Prayson RA, "Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme" 6 : 148-153, 2002

26 Chang CH, "Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas 997-1007다형성아교모세포종 환자에서 Cyclooxygenase-2 발현이생존율에 미치는 영향동아대학교 의과대학 방사선종양학교실* 다형성아교모세포종 환자들에서 cyclooxygenase-2 단백의 발현 정도와 생존율에 미치는 영향을 조사하고자 한다 대상 및 방법 1997년부터 2006년까지 다형성아교모세포종으로 수술 및 방사선치료를 받은 환자들 중에서" -2,

27 Masferrer JL, "Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors" 60 : 1306-1311, 2000

28 Walker MD, "An analysis of dose-effect relationship in the radiotherapy of malignant gliomas" 1725-1731,

29 Pyo H, "A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2" 7 : 2998-3005, 2001

30 Cancer 1991;68, "A randomized study of chemotherapy with procarbazine and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4" vincristine 22-29,

31 Lacroix M, "A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival" 95 : 190-198, 2001

32 Stenning SP, "A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma" 769-774,